Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Hum Pathol

Retrieve available abstracts of 22 articles:
HTML format

Single Articles

    March 2023
  1. SIEGMUND SE, Mehra R, Acosta AM
    An update on diagnostic tissue-based biomarkers in testicular tumors.
    Hum Pathol. 2023;133:32-55.
    PubMed     Abstract available

    January 2023
  2. LU B, Xia Y, Chen J, Tang J, et al
    NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: a clinicopathological and molecular study of 18 cases.
    Hum Pathol. 2023 Jan 13:S0046-8177(23)00012.
    PubMed     Abstract available

  3. WU Y, Li H, Tan L, Lai Y, et al
    Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas.
    Hum Pathol. 2023;131:87-97.
    PubMed     Abstract available

    December 2022
  4. VADASZ B, Felicelli C, Feng Y, Yin P, et al
    Loss of Dystrophin is common in Uterine Leiomyosarcoma: a potential biomarker for clinical application.
    Hum Pathol. 2022 Dec 19:S0046-8177(22)00289.
    PubMed     Abstract available

  5. VELEZ TORRES JM, Zhao J, Epstein JI, Kryvenko ON, et al
    Condyloma acuminatum of the urinary tract demonstrates atypical squamous cells in urine cytology.
    Hum Pathol. 2022;130:110-116.
    PubMed     Abstract available

    October 2022
  6. KORENTZELOS D, Elishaev E, Zhao C, Jones MW, et al
    ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution.
    Hum Pathol. 2022 Oct 14. pii: S0046-8177(22)00242.
    PubMed     Abstract available

  7. ZAFAR R, Schrader LJ, Cheville JC, Schoolmeester JK, et al
    A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
    Hum Pathol. 2022;128:31-47.
    PubMed     Abstract available

    September 2022
  8. IMAI Y, Fukagawa Y, Sugihara S, Teranishi T, et al
    Reclassification of atypical immature metaplasia of the uterine cervix by combination of nuclear features on hematoxylin and eosin-stained sections without auxiliary immunohistochemistry.
    Hum Pathol. 2022;129:113-122.
    PubMed     Abstract available

    August 2022
  9. ZARE SY, Ciscato A, Fadare O
    Tumor budding activity is an independent prognostic factor in squamous cell carcinoma of the vulva.
    Hum Pathol. 2022;126:77-86.
    PubMed     Abstract available

    July 2022
  10. LIBERA L, Sahnane N, Pepe F, Pisapia P, et al
    Critical aspects of MSI testing in endometrial cancer: a comparison study.
    Hum Pathol. 2022 Jul 21. pii: S0046-8177(22)00187.
    PubMed     Abstract available

    June 2022
  11. LONDERO AP, Orsaria M, Viola L, Marzinotto S, et al
    Survivin, Sonic hedgehog, Kruppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study.
    Hum Pathol. 2022 Jun 28. pii: S0046-8177(22)00168.
    PubMed     Abstract available

    May 2022
  12. LI H, Yang W, Tu X, Yu L, et al
    Clinicopathological and molecular characteristics of fumarate-hydratase-deficient uterine smooth muscle tumors: A single-center study of 52 cases.
    Hum Pathol. 2022 May 31. pii: S0046-8177(22)00138.
    PubMed     Abstract available

  13. MCCLUGGAGE WG, Stewart CJR, Belcijan NL, Mourad S, et al
    Neuroectodermal elements are part of the morphological spectrum of DICER1-associated neoplasms.
    Hum Pathol. 2022;123:46-58.
    PubMed     Abstract available

    April 2022
  14. SILVA EG, Lawson BC, Ramalingam P, Liu J, et al
    Precursors in the Ovarian Stroma, Another Pathway to Explain the Origin of Ovarian Serous Neoplasms.
    Hum Pathol. 2022 Apr 12. pii: S0046-8177(22)00087.
    PubMed     Abstract available

  15. BOYRAZ B, James K, Hornick JL, Roberts DJ, et al
    Placental pathology from COVID-19 recovered (non-acute) patients.
    Hum Pathol. 2022 Apr 8. pii: S0046-8177(22)00084.
    PubMed     Abstract available

    March 2022
  16. YOSHIDA H, Kikuchi A, Tsuda H, Sakamoto A, et al
    Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese Clinical Oncology Group.
    Hum Pathol. 2022 Mar 23. pii: S0046-8177(22)00073.
    PubMed     Abstract available

  17. ZHANG L, Zhang L, Wang XI, Katz G, et al
    The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Hum Pathol. 2022 Mar 21. pii: S0046-8177(22)00070.
    PubMed     Abstract available

    February 2022
  18. DRIDI M, Papoudou-Bai A, Kanavaros P, Perard M, et al
    The immune microenvironment of the hydatidiform mole.
    Hum Pathol. 2022;120:35-45.
    PubMed     Abstract available

    January 2022
  19. DUBUCS C, Groussolles M, Ousselin J, Sartor A, et al
    Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death.
    Hum Pathol. 2022 Jan 4. pii: S0046-8177(21)00220.
    PubMed     Abstract available

    November 2021
  20. FITZPATRICK MB, Hammer PM, Yang EJ, Howitt BE, et al
    Intravascular adenomyomatosis: a morphologic variant of intravenous leiomyomatosis associated with endometriosis and potential for misdiagnosis.
    Hum Pathol. 2021 Nov 29. pii: S0046-8177(21)00197.
    PubMed     Abstract available

    October 2021
  21. SMITHGALL MC, Remotti H, Hsiao SJ, Mansukhani M, et al
    Investigation of Discrepant MMR IHC and MSI PCR Test Results for Gynecologic Cancers using Next Generation Sequencing.
    Hum Pathol. 2021 Oct 16. pii: S0046-8177(21)00182.
    PubMed     Abstract available

    July 2021
  22. SIATECKA H, Masand RP
    Brenner tumor associated with rete ovarii: a histologic and immunohistochemical analysis of six cases exploring the relationship between these entities.
    Hum Pathol. 2021;113:84-91.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.